glp 1 drugs and cancer GLP-1 linked to lower rates of some cancers Long-term cancer risk in users
Description
doi: 10.1053/j.gastro.2004.04.063 27 SmitsMMTonneijckLMuskietMHAKramerMHHCahenDLvan RaalteDH
Back Couzin-Frankel, J (22 Sept 2023), 'Sidelined', Science , 381/6664, 1274-77
doi: 10.1038/304368a0 14 HansenLDeaconCFOrskovCHolstJJ
He had done this while a postdoctoral fellow at Whitehead Institute for Biomedical Research in Cambridge, Massachusetts (Leemans)
Semaglutide, when used as a subcutaneous injection, has a half-life of 5-6 days
